Montara Therapeutics is developing more effective therapies for neurological diseases to improve patient outcomes. The team sought secure, expert business support—so they could focus on the science that drives progress in medicine.
Working with J.P. Morgan, Montara Therapeutics gained the strategic support to build a platform that delivers safer, more effective therapies for people with neurological diseases.
“Working with J.P. Morgan provided us with the clarity to move from early science to a scalable platform. It could help us make a real difference in patients' lives.”
—Nicholas Hertz, Founder and CEO, Montara
Whether you’re building a life sciences startup or preparing for public launch, we can help you reach your next milestone. Connect with J.P. Morgan Startup Banking today, and explore our Innovation Economy content hub for more insights.
JPMorgan Chase Bank, N.A. Member FDIC. Visit jpmorgan.com/commercial-banking/legal-disclaimer for disclosures and disclaimers related to this content.
